---
document_datetime: 2024-07-22 10:56:09
document_pages: 21
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/luveris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: luveris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 12.845605
conversion_datetime: 2025-12-21 17:53:25.395249
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Luveris

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                         | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IA/0100              | B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s)                                                         | 19/07/2024                          |                                             | SmPC, Labelling and PL           |           |
| WS/2638              | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. | 14/03/2024                          | n/a                                         |                                  |           |

1 Notifications  are issued for  type I variations  and Article  61(3) notifications  (unless part of a group including a type II variation  or extension  application  or a worksharing  application).  Opinions are  issued for all  other procedures.

2 A Commission  decision  (CD) is issued for procedures  that affect  the terms of the marketing  authorisation  (e.g.  summary of  product characteristics,  annex  II, labelling,  package  leaflet).  The CD is issued within two  months of  the opinion  for variations  falling  under the scope of  Article  23.1a(a)  of Regulation  (EU) No.  712/2012, or within  one year  for other procedures.

3 SmPC  (Summary  of Product Characteristics),  Annex  II, Labelling,  PL (Package  Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                    | Type II (B.I.b.2.d) - To replace the test procedure peptide mapping by RP-HPLC (Arg-C digestion) with peptide mapping by UPLC-UV (Lys-C digestion) for the biological active substance lutropin alfa (r-hLH). B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS   |            |     |                                   |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| WS/2649            | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                       | 22/02/2024 | n/a |                                   |
| PSUSA/1918/ 202211 | Periodic Safety Update EU Single assessment - lutropin alfa                                                                                                                                                                                                                                                                                                                                                                                                      | 06/07/2023 | n/a | PRAC Recommendation - maintenance |
| IA/0097            | B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method                                                                                                                                                                                                                                            | 02/06/2023 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0096   | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 25/05/2023   | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0094   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 23/08/2022   | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IB/0093   | B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 17/08/2022   | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| II/0091   | Update of sections 4.1, 4.2, 5.1 and 5.2 of the SmPC in order to update details regarding the definition of severe LH and FSH deficiency, to clarify follicular development as the treatment target and selection of the most adequate Medically Assisted Reproduction procedure for healthcare providers and to clarify the pharmacokinetic and pharmacodynamic properties of the two gonadotropins, in alignment with the variation EMEA/H/C/000714/II/0075 for Pergoveris, based on a systematic literature search and review. The Package Leaflet is updated accordingly. In addition, the MAH took the opportunity to introduce minor editorial changes to the PI. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 23/06/2022   | 26/05/2023 | SmPC and PL | Based on literature review data and in alignment with Pergoveris EMEA/H/C/000714/II/0075, sections 4.1, 4.2, 5.1 and 5.2 of the SmPC have been updated to remove LH threshold from the definition for severe LH and FSH deficiency, to add guidance to tailor treatment to individual patient's response, to clarify mechanism of action and to update pharmacodynamic and pharmacokinetic properties. Editorial amendments have also been performed. For more information, please refer to the Summary of Product Characteristics. |

<div style=\"page-break-after: always\"></div>

| IB/0092   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 30/03/2022   | n/a   |                      |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|----------------------|
| IA/0090/G | This was an application for a group of variations. B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of | 05/07/2021   | n/a   | specification limits |
| II/0089   | B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 06/05/2021   | n/a   |                      |
| IA/0088   | B.II.f.1.e - Stability of FP - Change to an approved stability protocol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 03/02/2021   | n/a   |                      |

<div style=\"page-break-after: always\"></div>

| IB/0087            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 07/01/2021   | 31/01/2022   | SmPC, Annex II, Labelling and PL   |                                   |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|-----------------------------------|
| PSUSA/1918/ 201911 | Periodic Safety Update EU Single assessment - lutropin alfa                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 09/07/2020   | n/a          |                                    | PRAC Recommendation - maintenance |
| WS/1799/G          | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.a.4.d - Change to in-process tests or limits applied during the manufacture of the AS - Widening of the approved in-process test limits, which may have a significant effect on the overall quality of the AS B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a | 18/06/2020   | n/a          |                                    |                                   |
| IB/0086/G          | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are                                                                                                                                                                                                         | 02/06/2020   | n/a          |                                    |                                   |

<div style=\"page-break-after: always\"></div>

|           | immunological medicinal products B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size   |            |     |                           |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------------------|
| II/0082   | C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required                                                                                                                                                                                                                | 28/11/2019 | n/a |                           |
| IB/0083/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure addition)                                                                                                                                  | 08/11/2019 | n/a | (including replacement or |

<div style=\"page-break-after: always\"></div>

|           | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                       | 11/07/2019   | n/a        |                        | IB/0079              |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|----------------------|
| IB/0080   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                    | 08/07/2019   | n/a        |                        |                      |
| IA/0081   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                    | 14/06/2019   | n/a        |                        |                      |
| IA/0078   | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                      | 13/02/2019   | n/a        |                        |                      |
| T/0077    | Transfer of Marketing Authorisation                                                                                                                                                                                                                             | 30/07/2018   | 20/08/2018 | SmPC, Labelling and PL |                      |
| IB/0076   | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                      | 21/02/2018   | n/a        |                        |                      |
| IB/0075/G | This was an application for a group of variations. B.II.b.4.f - Change in the batch size (including batch size ranges) of the finished product - The scale for a biological/immunological medicinal product is increased/decreased without process change (e.g. | 09/02/2018   | n/a        |                        | duplication of line) |

<div style=\"page-break-after: always\"></div>

|                    | B.II.e.4.c - Change in shape or dimensions of the container or closure (immediate packaging) - Sterile medicinal products                                                                                                                                                                                                                                                                                                                                     |            |            |                  |                                   |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------|-----------------------------------|
| IB/0074/G          | This was an application for a group of variations. B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates exist per material) | 30/08/2017 | n/a        |                  |                                   |
| N/0073             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                              | 11/07/2017 | 20/08/2018 | Labelling and PL |                                   |
| PSUSA/1918/ 201611 | Periodic Safety Update EU Single assessment - lutropin alfa                                                                                                                                                                                                                                                                                                                                                                                                   | 06/07/2017 | n/a        |                  | PRAC Recommendation - maintenance |
| IB/0070            | B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                                                                                                                                                                                                                                                   | 17/11/2016 | n/a        |                  |                                   |
| IB/0071            | To update the ultrafiltration 10kD membranes (Pall Omega C) used in steps I, II, V and VI of drug substance purification process with equivalent membranes (Pall Omega T) and to change the storage solution from 0.05M NaOH used for Pall Omega C to a 0.1M NaOH solution for Pall Omega T.                                                                                                                                                                  | 08/11/2016 | n/a        |                  |                                   |

<div style=\"page-break-after: always\"></div>

|         | In addition, MAH introduced editorial change to update the total surface area of the ultrafiltration membranes. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                  |            |            |                        |                                        |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------|
| IA/0069 | B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                 | 25/02/2016 | n/a        |                        |                                        |
| WS/0655 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Change in test procedure for AS and FP B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate | 20/11/2014 | n/a        |                        | Change in test procedure for AS and FP |
| IB/0067 | C.I.7.a - Deletion of - a pharmaceutical form                                                                                                                                                                                                                                                                                                                                                     | 19/11/2014 | 24/04/2015 | SmPC, Labelling and PL |                                        |
| IG/0500 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the                                                                                                                                                                                                                                                 | 17/11/2014 | n/a        |                        |                                        |

<div style=\"page-break-after: always\"></div>

|           | PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |            |     |           |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------|
| IA/0066   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 02/10/2014 | n/a |           |
| WS/0579/G | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.III.2.z - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Other variation B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation - Change to comply with Ph. Eur. or with a | 24/07/2014 | n/a | B.III.2.z |

<div style=\"page-break-after: always\"></div>

|           | variation B.III.2.z - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Other variation B.III.2.z - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Other variation B.III.2.z - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation   |            |     |                                   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IG/0461   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 22/07/2014 | n/a |                                   |
| PSUV/0062 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 10/07/2014 | n/a | PRAC Recommendation - maintenance |
| WS/0506   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Change to the manufacturing process of the active                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 20/03/2014 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|         | substance. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                          |            |            |                        |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IB/0061 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                       | 18/03/2014 | 24/04/2015 | SmPC, Labelling and PL |
| IG/0395 | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                         | 20/12/2013 | n/a        |                        |
| N/0056  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                     | 07/11/2013 | 18/12/2013 | PL                     |
| IG/0358 | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                  | 25/09/2013 | n/a        |                        |
| WS/0380 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Change to the control of the active substance B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits | 30/05/2013 | n/a        |                        |

<div style=\"page-break-after: always\"></div>

| IB/0054   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                          | 14/01/2013   | 18/12/2013   | SmPC, Annex II, Labelling and PL   |             |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|-------------|
| IG/0224   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                          | 11/10/2012   | n/a          |                                    |             |
| WS/0275   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Change to the control of the finished product B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation | 19/07/2012   | n/a          |                                    |             |
| IB/0046   | C.I.3.a - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under A 45/46, or amendments to reflect a Core SPC - Changes with NO new additional data are submitted by the MAH                                              | 21/10/2011   | n/a          | SmPC and PL                        |             |
| WS/0174   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Change to the manufacturing process of lutropin alfa active substance Changes in the manufacturing process of                                             | 20/10/2011   | 20/10/2011   |                                    | B.I.a.2.c - |

<div style=\"page-break-after: always\"></div>

|           | manufacture of a biological/immunological medicinal product and is not related to a protocol                                                                                                                                                                                                                                                                                                                                 |            |            |                           |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|---------------------------|
| WS/0148   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. New TSE certificate for a raw material used in the manufacture of the active substance. B.III.1.b.2 - Submission of a new or updated Ph. Eur. TSE Certificate of suitability - New certificate for a starting material/reagent/intermediate/or excipient approved manufacturer | 21/07/2011 | 21/07/2011 | from a new or an already  |
| IG/0087   | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State                                                                                                                                                                                                        | 18/07/2011 | n/a        |                           |
| IG/0076/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) impact on the operation of    | 01/07/2011 | n/a        | to the DDPS that does not |

<div style=\"page-break-after: always\"></div>

|           | the pharmacovigilance system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |            |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0044/G | This was an application for a group of variations. New pharmaceutical form: Luveris 450 IU solution for injection in a pre-filled pen. Additional sites for drug product manufacture. B.IV.1.c - Change of a measuring or administration device - Addition or replacement of a device which is an integrated part of the primary packaging B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for biological/immunological medicinal products. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site | 14/04/2011 | 23/05/2011 | SmPC, Labelling and PL | New pharmaceutical form: Luveris 450 IU solution for injection in a pre-filled pen. Additional sites for drug product manufacture.                                                                                                                                                                                                                                                                                                                         |
| IG/0069   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 12/05/2011 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| II/0045   | Update of SPC and package leaflet C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 17/02/2011 | 18/03/2011 | SmPC, Labelling and PL | The MAH is updating the product information according to the company core safety data sheet. These changes include addition of a warning to include patients with porphyria, multiple pregnancy, recent thromboembolic disease and rewording of OHSS. In addition the product information will be amended according to the last QRD template, minor linguistic improvements and revised name and/or address of some local representatives of the Marketing |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                                                                                                                                                                                                                                                                                   |            |            |                        | Authorisation Holder.                                                                                                                                                                                                                                                                                                                                |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| WS/0016 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Change of reference standard B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting | 24/06/2010 | 24/06/2010 |                        |                                                                                                                                                                                                                                                                                                                                                      |
| II/0043 | Update of DDPS (Pharmacovigilance)                                                                                                                                                                                                                                                                                                                                | 22/04/2010 | 17/06/2010 | Annex II               | With this variation the MAH submitted a new version of the DDPS (core version 9.0) in accordance with the current Pharmacovigilance guideline. After assessing the documentation the CHMP concluded that the submitted DDPS contained all required elements. Consequently, Annex II has been updated with the new version number of the agreed DDPS. |
| IA/0042 | IA_01_Change in the name and/or address of the marketing authorisation holder                                                                                                                                                                                                                                                                                     | 09/07/2009 | n/a        | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                      |
| X/0037  | Registration of an additional pharmaceutical form corresponding to a solution for injection in a cartridge (450 IU). This multidose formulation is intended to be used in the same clinical indication, posology and route of administration (subcutaneous injection) as the existing pharmaceutical form                                                         | 19/03/2009 | 26/05/2009 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                      |

<div style=\"page-break-after: always\"></div>

|         | IU). Annex I_2.(d) Change or addition of a new pharmaceutical form                                                                                                                   |            |            |                                  |                                                                                                                                                                                                                                         |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0041 | IA_04_Change in name and/or address of a manuf. of the active substance (no Ph. Eur. cert. avail.) IA_05_Change in the name and/or address of a manufacturer of the finished product | 26/02/2009 | n/a        | Annex II and PL                  |                                                                                                                                                                                                                                         |
| IA/0040 | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                                                                    | 27/10/2008 | n/a        | Annex II and PL                  |                                                                                                                                                                                                                                         |
| II/0038 | Additional sites for the production of a raw material used in the manufacture of the active substance Change(s) to the manufacturing process for the active substance                | 25/09/2008 | 02/10/2008 |                                  |                                                                                                                                                                                                                                         |
| IB/0039 | IB_31_a_Change to in-process tests/limits during manufacture - tightening of in-process limits                                                                                       | 01/10/2008 | n/a        |                                  |                                                                                                                                                                                                                                         |
| IA/0036 | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                                                                    | 20/02/2008 | n/a        |                                  |                                                                                                                                                                                                                                         |
| N/0035  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                     | 20/06/2007 | n/a        | PL                               |                                                                                                                                                                                                                                         |
| R/0033  | Renewal of the marketing authorisation.                                                                                                                                              | 15/09/2005 | 24/01/2006 | SmPC, Annex II, Labelling and PL | Based on the CHMP review of the available information, the CHMP considered that the quality, the efficacy and the safety of this medicinal product continues to be adequately and sufficiently demonstrated and therefore considered by |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                  |            |            |              | approved therapeutic indication remains favourable. The Committee for Medicinal Products for Human Use recommended therefore the renewal of the Marketing Authorisation for Luveris. The CHMP was of the opinion that no additional 5-year renewal is required. The renewal required amendments to the terms of the Community Marketing Authorisation. The following annexes have been amended: I, II, IIIA and IIIB. Future PSURs submission will take place in accordance to Article 24(3) of Regulation EC 726/2004.   |
|---------|--------------------------------------------------------------------------------------------------|------------|------------|--------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0032 | IB_37_a_Change in the specification of the finished product - tightening of specification limits | 10/06/2005 | n/a        |              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IB/0031 | IB_12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening      | 10/06/2005 | n/a        |              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IA/0030 | IA_16_b_Submission of new TSE certificate relating to active substance - other substances        | 02/03/2005 | n/a        |              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| N/0028  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 26/11/2004 | n/a        | PL           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IA/0029 | IA_05_Change in the name and/or address of a manufacturer of the finished product                | 28/10/2004 | n/a        |              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| II/0026 | Change(s) to the test method(s) and/or specifications for the active substance                   | 16/09/2004 | 22/09/2004 |              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| N/0027  | The Marketing Authorisation Holder applied for an                                                | 21/07/2004 | n/a        | Annex II and |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

|         | update of the list of the local representatives in order to include the contact details of the Marketing Authorisations Holder in the new Member States. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   |            |            | PL   |                 |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------|
| II/0025 | Change in the manufacturing process of the finished product.                                                                                                                                                                                                | 23/06/2004 | 01/07/2004 |      | Quality changes |
| II/0024 | Extension of the shelf life of the active substance. Change(s) to shelf-life or storage conditions                                                                                                                                                          | 22/04/2004 | 27/04/2004 |      |                 |
| IB/0023 | IB_42_a_01_Change in shelf-life of finished product - as packaged for sale                                                                                                                                                                                  | 15/01/2004 | n/a        | SmPC |                 |
| I/0021  | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process                                                                                                                                                              | 08/10/2003 | 15/10/2003 |      |                 |
| I/0022  | 31_Change in container shape                                                                                                                                                                                                                                | 15/08/2003 | 22/09/2003 | SmPC |                 |
| II/0020 | Change(s) to the test method(s) and/or specifications for the active substance                                                                                                                                                                              | 26/06/2003 | 02/07/2003 |      |                 |
| I/0019  | 20a_Extension of shelf-life or retest period of the active substance                                                                                                                                                                                        | 08/05/2003 | 14/05/2003 |      |                 |
| N/0018  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                            | 10/02/2003 | 04/03/2003 | PL   |                 |

<div style=\"page-break-after: always\"></div>

| I/0017   | 15a_Change in IPCs applied during the manufacture of the product                                     | 16/01/2003   | 22/01/2003   |                        |
|----------|------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|
| I/0016   | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process       | 28/11/2002   | 04/12/2002   |                        |
| I/0015   | 11b_Change in supplier of an intermediate compound used in manufacture of the active substance       | 21/08/2002   | 18/09/2002   |                        |
| II/0006  | Change in formulation                                                                                | 21/02/2002   | 15/05/2002   | SmPC, Labelling and PL |
| I/0012   | 20_Extension of shelf-life as foreseen at time of authorisation                                      | 10/11/2001   | 28/01/2002   | SmPC                   |
| I/0014   | 17_Change in specification of the medicinal product                                                  | 14/01/2002   | 23/01/2002   |                        |
| I/0009   | 24_Change in test procedure of active substance                                                      | 19/10/2001   | 05/11/2001   |                        |
| I/0008   | 25_Change in test procedures of the medicinal product                                                | 19/10/2001   | 05/11/2001   |                        |
| I/0004   | 25_Change in test procedures of the medicinal product                                                | 19/10/2001   | 05/11/2001   |                        |
| I/0011   | 12a_Change in specification of starting material/intermediate used in manuf. of the active substance | 12/09/2001   | n/a          |                        |

<div style=\"page-break-after: always\"></div>

| I/0007   | 24_Change in test procedure of active substance                 | 20/08/2001   | n/a        |                        |                         |
|----------|-----------------------------------------------------------------|--------------|------------|------------------------|-------------------------|
| I/0005   | 03_Change in the name and/or address of the holder              | 20/07/2001   | n/a        | SmPC, Labelling and PL | marketing authorisation |
| I/0001   | 20_Extension of shelf-life as foreseen at time of authorisation | 11/02/2001   | 17/05/2001 | SmPC                   |                         |
| I/0003   | 26_Changes to comply with supplements to pharmacopoeias         | 16/02/2001   | n/a        |                        |                         |